XML 18 R7.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows - operating activities    
Net income $ 52,025 $ 23,704
Adjustments to reconcile net income to net cash used in operating activities:    
Depreciation and amortization 15,245 13,650
Deferred income taxes (1,572) (2,060)
Stock-based compensation expense 9,416 9,901
Accretion expense related to earnout payments 1,534 1,413
Gain on marketable securities (4,460) (2,323)
Loss on disposal of property and equipment 42 264
Impairment charges 0 16,224
Changes in assets and liabilities:    
Accounts receivable (63,561) (51,707)
Accounts payable (6,334) 103
Accrued expenses (12,238) (41,372)
Restructuring accrual (1,881) 2,990
Deferred revenue 3,632 1,163
Income taxes recoverable and payable, net (7,297) 347
Retirement and pension plan assets and liabilities 5,329 6,385
Prepaid expenses (1,922) (4,057)
Other assets and liabilities, net (16,893) (987)
Net cash used in operating activities (28,935) (26,362)
Cash flows - investing activities    
Capital expenditures (12,141) (23,042)
Purchases of marketable securities and investments (362,295) (115,608)
Proceeds from sales of marketable securities and investments 335,839 129,070
Net cash used in investing activities (38,597) (9,580)
Cash flows - financing activities    
Debt issuance costs (360) 0
Cash dividends paid (9,705) (9,609)
Payment of employee tax withholdings on equity transactions (4,093) (3,800)
Net cash used in financing activities (14,158) (13,409)
Effect of exchange rate fluctuations on cash, cash equivalents and restricted cash 20,786 155
Net decrease in cash, cash equivalents and restricted cash (60,904) (49,196)
Cash, cash equivalents and restricted cash at beginning of period 515,813 412,618
Cash, cash equivalents and restricted cash at end of period $ 454,909 $ 363,422